Smallwood Wealth Investment Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$282K Hold
3,081
0.12% 76
2026
Q1
$263K Sell
3,081
-468
-13% -$41.7K 0.14% 70
2025
Q4
$280K Hold
3,549
0.15% 69
2025
Q3
$284K Hold
3,549
0.14% 72
2025
Q2
$323K Sell
3,549
-1,100
-24% -$100K 0.18% 57
2025
Q1
$436K Hold
4,649
0.27% 47
2024
Q4
$423K Hold
4,649
0.29% 51
2024
Q3
$483K Hold
4,649
0.34% 41
2024
Q2
$451K Hold
4,649
0.35% 42
2024
Q1
$419K Hold
4,649
0.32% 46
2023
Q4
$371K Hold
4,649
0.31% 45
2023
Q3
$331K Hold
4,649
0.3% 46
2023
Q2
$358K Hold
4,649
0.32% 44
2023
Q1
$349K Hold
4,649
0.33% 44
2022
Q4
$366K Sell
4,649
-223
-5% -$16.7K 0.31% 51
2022
Q3
$342K Hold
4,872
0.31% 55
2022
Q2
$390K Hold
4,872
0.4% 44
2022
Q1
$369K Hold
4,872
0.35% 41
2021
Q4
$416K Buy
+4,872
New +$380K 0.39% 39

Other funds holding CL

Smallwood Wealth Investment Management's CL Position: Q2 2026 in Review

Smallwood Wealth Investment Management held its Colgate-Palmolive (CL) position steady in Q2 2026 at 3,081 shares worth $282K. The position accounts for 0.12% of the portfolio, ranked #76.

Smallwood Wealth Investment Management first reported a position in CL in Q4 2021 and has held it in 19 quarters since. The position peaked at $483K in Q3 2024. 597 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Smallwood Wealth Investment Management held 3,081 shares of Colgate-Palmolive worth $282K as of Q2 2026.
  • Smallwood Wealth Investment Management left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.12% of Smallwood Wealth Investment Management's portfolio in Q2 2026, its #76 holding.
  • Smallwood Wealth Investment Management first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 19 quarters since.
  • Smallwood Wealth Investment Management's Colgate-Palmolive position peaked at $483K in Q3 2024.
  • 597 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Smallwood Wealth Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.